It's FDA-approved with decades of data behind it
In one single-center trial of 72 subjects using a controlled-adverse-environment model, the T4 eye drop did not meet its co-primary endpoints (ocular discomfort and inferior corneal staining) at the primary time point, but it did produce statistically significant improvements on several secondary endpoints, including central and superior corneal staining, with no adverse events reported
Its important for doctors and patients to know these rules
If your peptide isn't dissolving quickly, letting the BAC water sit for 510 minutes at room temperature can help
J Neurol 270:477485 Phokaewvarangkul O et al (2023) Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinsons disease: clinical and therapeutic considerations
Light protection GHK-Cu demonstrates significant light sensitivity due to copper-catalyzed photodegradation